金禾实业(002597) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 reached ¥1,544,950,805.99, representing a 74.93% increase compared to the same period last year[6]. - Net profit attributable to shareholders was ¥274,087,666.21, up 55.43% year-on-year[6]. - The net profit after deducting non-recurring gains and losses was ¥222,762,675.23, reflecting a 63.39% increase compared to the previous year[6]. - Total revenue for the third quarter of 2021 reached ¥4,019,340,205.23, a significant increase of 48.1% compared to ¥2,712,177,274.26 in the same period of 2020[33]. - The net profit for the third quarter was 712,945,580.69 CNY, an increase from 532,754,776.64 CNY in the previous year, representing a growth of approximately 33.8%[36]. - The total profit was 854,375,253.31 CNY, up from 629,931,614.13 CNY, marking an increase of around 35.6%[36]. - The basic earnings per share (EPS) increased to 1.27 CNY from 0.95 CNY, reflecting a growth of approximately 33.7%[39]. - The total comprehensive income attributable to the parent company was 713,345,466.89 CNY, compared to 532,658,625.87 CNY in the previous year, reflecting an increase of approximately 33.9%[39]. Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥8,175,302,910.66, a 16.82% increase from the end of the previous year[6]. - The company's total assets as of September 30, 2021, amounted to ¥8,175,302,910.66, an increase of 17% from ¥6,998,152,136.98 at the end of 2020[32]. - Current assets totaled ¥4,955,282,394.52, reflecting a growth of 20.8% from ¥4,102,412,178.43 year-over-year[28]. - Non-current assets increased to ¥3,220,020,516.14, up 11.2% from ¥2,895,739,958.55 in the previous year[29]. - The company's total liabilities reached ¥2,828,900,386.99, an increase of 37.8% compared to ¥2,051,151,637.26 in 2020[32]. - The company's equity attributable to shareholders reached ¥4,945,909,384.69, with total equity standing at ¥4,947,000,499.72[54]. Cash Flow and Investment - The company's cash flow from operating activities for the year-to-date was ¥571,911,048.97, showing a 9.52% increase[6]. - Cash flow from operating activities generated a net amount of 571,911,048.97 CNY, compared to 522,212,155.82 CNY in the previous year, showing a slight increase of about 9.4%[43]. - The company experienced a significant increase in investment cash inflow, totaling 1,852,160,149.74 CNY, compared to 757,115,693.94 CNY in the previous year, which is an increase of approximately 144.5%[43]. - The company reported a significant increase in investment income, which rose by 451.45% to ¥63,936,213.92, driven by gains from financial assets[12]. - The company reported a significant increase in investment income, totaling 63,936,213.92 CNY, compared to 11,594,206.35 CNY in the previous year, which is an increase of about 450.5%[36]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 32,910, with the largest shareholder, Anhui Jinrui Investment Group Co., Ltd., holding 44.66% of shares, totaling 250,487,223 shares[13]. - The top ten shareholders include various institutional investors, with the second-largest shareholder holding 2.53% of shares[13]. - The company has not disclosed any related party transactions among the top ten shareholders[16]. - The company has not reported any financing or securities lending activities among the top ten shareholders[17]. Research and Development - Research and development expenses increased by 40.10% to ¥146,536,333.46, indicating a focus on innovation[12]. - Research and development expenses for the third quarter were ¥146,536,333.46, up 40.2% from ¥104,591,705.29 in the same period last year[33]. Corporate Actions - The company has repurchased a total of 2,207,300 shares, accounting for 0.39% of the total shares, with a total transaction amount of RMB 67,815,775.40[18]. - The maximum repurchase price for shares is set at RMB 45.00 per share, with a total repurchase fund between RMB 50 million and RMB 100 million[18]. - The company has completed a share transfer and related registration for Beijing Jinhe Yikang Biotechnology Co., Ltd., increasing its ownership from 40% to 55%[21]. - The company has transferred 60% of the shares of its wholly-owned subsidiary, Nanjing Jinhe Yikang Biotechnology Co., Ltd., to its actual controller, Yang Le, and will not exercise its preemptive rights for this capital increase[22]. - The company has increased its capital in three subsidiaries: Jin Hong New Energy Technology Co., Ltd. by RMB 75 million, Chuzhou Jinwo Biotechnology Co., Ltd. by RMB 100 million, and Anhui Jinxuan Technology Co., Ltd. by RMB 150 million[22]. Financial Management - The company’s cash and cash equivalents increased to ¥2,010,654,327.71, up 76.7% from ¥1,138,980,405.07 in the previous year[28]. - The cash and cash equivalents at the end of the period amounted to 844,666,135.93 CNY, up from 535,284,429.31 CNY, representing a growth of about 57.7%[45]. - The company incurred financial expenses of 17,263,760.21 CNY, a decrease from 9,568,552.80 CNY in the previous year, indicating a reduction in financial costs[36]. - The company experienced a 137.75% increase in contract liabilities, indicating a rise in customer prepayments[9]. - The company’s total liabilities decreased by 39.32% in short-term borrowings, reflecting improved financial management[9].